Overview
Recist Teleradiologia Onkologiczna is preparing to launch expert teleradiology and CT reporting for oncology. Services will cover drug programs, clinical trials, and response assessment for chemotherapy, immunotherapy, and radiotherapy using RECIST 1.1 and iRECIST; the team reports over 20 years of experience and more than 100,000 examinations interpreted.
Industry
Offer
- Computed tomography report writing
- Treatment response assessment
- Radiological second opinion
- Lung cancer screening assessment
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Radosław Kaliszage 44 | 460 | $12,425.72 | 92% |
Others | 40 | $1,080.50 | 8% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Affidea Onkoterapiasp. z o.o. | $29,529,691.81 | affidea.pl | ||
| Diagnostyka - Teleradiologia24sp. z o.o. | $10,018,477.01 | teleradiologia24.pl | ||
| Rekol-Medsp. z o.o. | $3,216,810.07 | rekolmed.pl | ||
| Eurodiagnosissp. z o.o. | $2,285,077.53 | eurodiagnosis.pl | ||
| Quadiasp. z o.o. + limited partnership | $2,151,119.92 | quadia.pl | ||
| Telediagnosis Apexsp. z o.o. | $2,141,156.52 | telediagnosis-apex.pl | ||
| Telediagnosis Visionsp. z o.o. | $2,136,529.25 | telediagnosis.pl | ||
| Hospital Investment Group Diagnostykasp. z o.o. | $952,182.35 | teleradiologia24.pl | ||
| BS Radiologiasp. z o.o. | $295,006.71 | bsradiologia.com | ||
| Onkomedicasp. z o.o. | $69,344.55 | onkomedica.pl |
Last updated: 2026-07-11